Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Differences in the glycosylation of recombinant and native human milk bile salt-stimulated lipase revealed by peptide mapping.
J Chromatogr A. 1995 Dec 1;718(1):53-8. Unique Identifier : AIDSLINE MED/96129766 Stromqvist M; Lindgren K; Hansson L; Juneblad K; ASTRA HASSLE AB, Umea, Sweden.
Abstract:
The milk of some mammals contains a bile salt-stimulated lipase (BSSL). Human milk BSSL is heavily glycosylated (30-40% carbohydrate) and present at a concentration of approximately 100-200 mg/l, thereby being one of the most abundant human whey proteins. BSSL has been shown to have an important role in the uptake of energy from human milk. The risk of HIV contamination has restricted the use of banked human milk for nutritional purposes. This has evoked an interest in the production of a recombinant form of the protein for supplementation of formula. We have produced BSSL in mouse C127 and hamster CHO cells, and used chromatographic methods for the characterization of the products. This study was focused on study of the glycosylation of the protein by using peptide mapping and isolation of glycosylated fragments. The results show how human BSSLs from different sources differ both in extent of glycosylation, in glycan heterogeneity, and in lectin binding.
Keywords: Animal Cells, Cultured Chromatography, Gel Cyanogen Bromide Glycoproteins/*CHEMISTRY Glycosylation Hamsters Human Lectins/METABOLISM Lipase/*CHEMISTRY Mice Milk/*ENZYMOLOGY Molecular Weight Peptide Fragments/ANALYSIS/CHEMISTRY Peptide Mapping/METHODS Peptide Peptidohydrolases/METABOLISM Recombinant Proteins/CHEMISTRY Support, Non-U.S. Gov't JOURNAL ARTICLE 960530
M9651041
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.